Merck Parteck COAT excipient

Wednesday, 06 November, 2019 | Supplied by: Merck Pty Ltd


Merck has launched its Parteck COAT excipient — a functional material designed for immediate release film coating applications.

The excipient is a particle engineered polyvinyl alcohol (PVA) with a particle structure that enables rapid dissolution even at low temperatures; this is said to lead to increased process efficiency. The water-soluble particle offers batch-to-batch consistency, contributing to the quality and performance of the final drug product.

The material offers low viscosity in solution, even at high concentrations of 20%, leading to high efficacy. Compared with existing PVAs for coating applications, it has the potential to double the polymer concentration and cut the process time in half.

Other advantages include: a stable moisture barrier to improve stability of moisture-sensitive drug substances; good surface finishing to increase the value of drug formulations; and a high concentration of spraying liquid to increase coating efficacy.

The product is compliant with and surpasses the requirements of all major pharmacopoeias, including United States Pharmacopoeia, European Pharmacopoeia, Chinese Pharmacopoeia and Japanese Pharmaceutical Excipients.

Online: www.sigmaaldrich.com/AU/en
Phone: 1800 800 097
Related Products

Beckman Coulter Life Sciences IR820 and IR870 infrared dye antibody conjugates

The products provide research flow cytometry labs with a low-noise solution, including single...

AdipoGen Life Sciences PANoptosis research antibodies

AdipoGen Life Sciences provides thoroughly validated and published antibodies for PANoptosis,...

Cytek 16-Color NK Cell Immunoprofiling Panel

The Cytek 16-Color NK Cell Immunoprofiling Panel is designed and optimised by Cytek scientists to...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd